Simplex Trading’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-116
Closed -$3K 7318
2017
Q2
$3K Sell
116
-85
-42% -$255 ﹤0.01% 5160
2017
Q1
$10K Buy
+201
New +$793 ﹤0.01% 4029
2016
Q1
Sell
-11
Closed -$2K 7021
2015
Q4
$2K Sell
11
-3
-21% -$72 ﹤0.01% 4735
2015
Q3
$2K Buy
14
+3
+27% +$103 ﹤0.01% 4892
2015
Q2
$13K Sell
11
-10
-48% -$598 ﹤0.01% 2887
2015
Q1
$63K Buy
21
+11
+110% +$682 0.01% 1402
2014
Q4
$14K Buy
+10
New +$502 ﹤0.01% 2363

Simplex Trading's OREX Position: Q3 2018 in Review

Simplex Trading sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2018, closing a stake of 5,500 shares.

Simplex Trading first reported a position in OREX in Q4 2014 and held it in 12 quarters. The position peaked at $79K in Q4 2014. 1 fund tracked by Wall St. Rank holds OREX as of Q3 2018.

  • Simplex Trading reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 5,500 Orexigen Therapeutics, Inc. shares in Q3 2018.
  • Simplex Trading first reported a position in Orexigen Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • Simplex Trading's Orexigen Therapeutics, Inc. position peaked at $79K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.